Sotac Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis

SOTAC Pharmaceuticals
Screen Sotac Pharmaceuticals share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap ₹136.08 Cr.
P/E Ratio (TTM) 15.00
P/B Ratio 2.69
EPS (TTM) ₹7.26
Dividend Yield -
Debt to Equity 0.70
52W High -
52W Low -
Operating Margin 8.00%
Profit Margin 3.57%
Revenue (TTM) ₹28.00
EBITDA ₹3.00
Net Income ₹1.00
Total Assets ₹124.00
Total Equity ₹58.00
Last updated: Jan 09, 2026

Sotac Pharmaceuticals Share Price History - Stock Screener Chart

Screen SOTAC historical share price movements with interactive charts. Analyze price trends and patterns.

Sotac Pharmaceuticals Company Profile - Fundamental Screener

Screen Sotac Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SOTAC shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE0O2D01012

Sotac Pharmaceuticals Balance Sheet Screener - Fundamental Analysis

Fair Value Analysis
Screen SOTAC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2021 2020
Assets
Total Assets 124 105 74 35 30
Current Assets 70 61 47 17 14
Fixed Assets 49 36 26 17 16
Liabilities
Total Liabilities 124 105 74 35 30
Current Liabilities 14 12 8 9 6
Non-Current Liabilities 0 0 0 0 0
Shareholders' Equity
Total Equity 58 49 20 3 5
Share Capital 11 11 8 2 2
Reserves & Surplus 42 34 2 0 1

Sotac Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis

Intrinsic Value
Screen SOTAC income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
Item 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec 2022-Sept
Revenue 28 26 27 26 27 25 18 20 41
Expenses 25 23 25 23 25 23 16 18 36
EBITDA 3 3 2 3 2 3 3 2 4
Operating Profit % 8.00% 9.00% 4.00% 10.00% 8.00% 9.00% 13.00% 9.00% 9.00%
Depreciation 1 1 1 1 1 1 1 1 1
Interest 1 0 0 1 1 1 1 0 1
Profit Before Tax 1 1 0 2 1 2 1 1 2
Tax 1 0 -1 1 0 0 0 0 1
Net Profit 1 2 2 1 1 1 1 1 1
EPS 0.42 1.32 1.49 0.82 0.58 1.01 1.58 0.29 4.41

Sotac Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals

Screen SOTAC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2021-March 2020-March
Operating Activities -4 -16 8 0 0
Investing Activities -14 -20 -12 -3 -12
Financing Activities 16 30 13 3 11
Net Cash Flow -2 -6 10 0 0

Sotac Pharmaceuticals Shareholding Pattern Screener - Ownership Analysis

Screen SOTAC shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
Item 2025-Sept 2025-Mar 2024-Sept 2024-Mar 2023-Sept 2023-Apr
Promoter Holding 72.85% 72.85% 72.85% 72.85% 72.85% 72.85%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 5.13% 4.70% 6.01% 5.82% 5.32% 8.19%
Other Holding 22.02% 22.45% 21.14% 21.33% 21.83% 18.96%
Shareholder Count 240 243 251 245 255 784

Sotac Pharmaceuticals Dividend Screener - Share Yield Analysis

Screen SOTAC dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
No dividends declared by Sotac Pharmaceuticals.

Sotac Pharmaceuticals Index Membership - Market Screener Classification

Screen SOTAC by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Sotac Pharmaceuticals is not part of any tracked indices.
Only major market indices are tracked in our system.

Sotac Pharmaceuticals Market Events Screener - Corporate Actions

Screen SOTAC market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -12.52%
Dividend ₹ 0.10 /share 1.16%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -0.65%
2025-05-28 2025-05-28 Quarterly Result Announcement NA -0.21%
2024-10-29 2024-10-29 Quarterly Result Announcement NA -4.97%

Sotac Pharmaceuticals Competitors Screener - Peer Comparison

Screen SOTAC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 413,165 39.35 54,729 9.71% 10,980 39.06
Divis Laboratories 169,741 68.64 9,712 18.67% 2,191 44.96
Torrent Pharmaceuticals 129,611 60.42 11,539 6.99% 1,911 59.35
Cipla 120,964 22.17 28,410 7.12% 5,291 42.76
Dr Reddys Laboratories 105,723 18.42 33,741 16.73% 5,725 49.97
Lupin 95,252 21.87 22,910 13.74% 3,306 50.10
Zydus Life Science 91,889 18.03 23,511 18.55% 4,615 34.06
Mankind Pharma 90,161 50.11 12,744 20.90% 2,007 40.67
Aurobindo Pharma 68,831 20.16 32,346 9.43% 3,484 46.33
Alkem Laboratories 65,940 26.89 13,458 3.70% 2,216 37.45

Sotac Pharmaceuticals Company Announcements - News Screener

Screen SOTAC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.

No company announcements available.

Back to Screener